Universitätsfrauenklinik Ulm
Ulm, Germany
Women's health clinic in Ulm, Baden-Württemberg
Prittwitzstraße 43, 89081 Ulm
About Universitätsfrauenklinik Ulm
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
AGO Study Group
4
AGO Research GmbH
3
Incyte Corporation
2
Swiss Group for Clinical Cancer Research
2
Aprea Therapeutics
1
Daiichi Sankyo, Inc.
1
Genentech, Inc.
1
Grupo Español de Investigación en Cáncer de Ovario
1
Karolinska University Hospital
1
Karyopharm Therapeutics Inc
1
Clinical Trials at Universitätsfrauenklinik Ulm
During the past decade, Universitätsfrauenklinik Ulm conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on
average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer
2006-01-01
2011-12-01
Completed
105
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
2007-09-01
Completed
73
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
2007-02-01
2022-01-01
Unknown status
2,017
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
2008-06-01
2012-01-01
Completed
41
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
2010-07-01
2020-12-31
Completed
408
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitätsfrauenklinik Ulm" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "AGO Study Group" with 4 trials
sponsored, "AGO Research GmbH" with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Swiss Group for Clinical Cancer Research"
with 2 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsfrauenklinik Ulm"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 3 trials as a collaborator, "German Breast Group" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were
collaborators in the rest 42 trials.
Clinical Trials Conditions at Universitätsfrauenklinik Ulm
According to Clinical.Site data, the most researched conditions in "Universitätsfrauenklinik Ulm" are
"Breast Cancer" (7 trials), "Ovarian Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Endometrial Cancer" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Universitätsfrauenklinik Ulm" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsfrauenklinik Ulm
Most popular intervention types in "Universitätsfrauenklinik Ulm" are "Drug" (25 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (7 trials), "Carboplatin" (6 trials), "Placebo" (6 trials), "Atezolizumab" (4 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsfrauenklinik Ulm
The vast majority of trials in "Universitätsfrauenklinik Ulm" are
21 trials for "Female" genders and 7 trials for "All" genders.
Clinical Trials Status at Universitätsfrauenklinik Ulm
Currently, there are NaN active trials in "Universitätsfrauenklinik Ulm".
undefined are not yet recruiting,
9 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Universitätsfrauenklinik Ulm,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsfrauenklinik Ulm, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".